USD 1.24
(2.48%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 49.74 Million USD | -10.1% |
2022 | 55.33 Million USD | 27.38% |
2021 | 43.43 Million USD | -86.84% |
2020 | 330.03 Million USD | 0.51% |
2019 | 328.36 Million USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 28.43 Million USD | -11.82% |
2024 Q1 | 32.24 Million USD | -35.18% |
2023 FY | 49.74 Million USD | -10.1% |
2023 Q3 | 50.54 Million USD | -1.07% |
2023 Q2 | 51.09 Million USD | -7.65% |
2023 Q1 | 55.32 Million USD | -0.0% |
2023 Q4 | 49.74 Million USD | -1.59% |
2022 Q3 | 52.58 Million USD | 22.65% |
2022 Q2 | 42.87 Million USD | 5.35% |
2022 Q1 | 40.69 Million USD | -6.3% |
2022 FY | 55.33 Million USD | 27.38% |
2022 Q4 | 55.33 Million USD | 5.22% |
2021 Q4 | 43.43 Million USD | -86.86% |
2021 FY | 43.43 Million USD | -86.84% |
2021 Q3 | 330.47 Million USD | 0.92% |
2021 Q2 | 327.44 Million USD | 0.0% |
2021 Q1 | - USD | -100.0% |
2020 Q1 | - USD | 0.0% |
2020 FY | 330.03 Million USD | 0.51% |
2020 Q4 | 330.03 Million USD | 0.0% |
2019 FY | 328.36 Million USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Abbott Laboratories | 34.38 Billion USD | 99.855% |
Allurion Technologies Inc. | 142.19 Million USD | 65.02% |
Artivion, Inc. | 510.61 Million USD | 90.259% |
Avanos Medical, Inc. | 456.1 Million USD | 89.094% |
Butterfly Network, Inc. | 84.22 Million USD | 40.94% |
Butterfly Network, Inc. | 84.22 Million USD | 40.94% |
Bio-Rad Laboratories, Inc. | 3.55 Billion USD | 98.602% |
Boston Scientific Corporation | 15.6 Billion USD | 99.681% |
CONMED Corporation | 1.46 Billion USD | 96.607% |
Edwards Lifesciences Corporation | 2.64 Billion USD | 98.119% |
Paragon 28, Inc. | 162.95 Million USD | 69.476% |
Glaukos Corporation | 478.64 Million USD | 89.608% |
Globus Medical, Inc. | 1.08 Billion USD | 95.429% |
Inspire Medical Systems, Inc. | 104.29 Million USD | 52.308% |
Integer Holdings Corporation | 1.41 Billion USD | 96.48% |
Medtronic plc | 39.56 Billion USD | 99.874% |
Myomo, Inc. | 5.59 Million USD | -789.468% |
Nevro Corp. | 330.31 Million USD | 84.941% |
Owlet, Inc. | 73.79 Million USD | 32.599% |
Penumbra, Inc. | 377.36 Million USD | 86.819% |
Vicarious Surgical Inc. | 21.89 Million USD | -127.18% |
Smith & Nephew plc | 4.77 Billion USD | 98.957% |
STERIS plc | 4.74 Billion USD | 98.952% |
Stryker Corporation | 21.31 Billion USD | 99.767% |
Vapotherm, Inc. | 132.95 Million USD | 62.587% |
Zimmer Biomet Holdings, Inc. | 9 Billion USD | 99.448% |